Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2004-09-10
2009-08-25
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S577000, C514S859000, C424S401000
Reexamination Certificate
active
07579377
ABSTRACT:
Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefore, advantageously topically applicable gels, creams or lotions.
REFERENCES:
patent: 4717720 (1988-01-01), Shroot et al.
patent: 7083799 (2006-08-01), Giacomoni
patent: 0 199 636 (1986-10-01), None
patent: 2 730 930 (1996-08-01), None
patent: WO 01/28552 (2001-04-01), None
Healy et al. British Medical Journal. 1994, vol. 308, Iss. 6932, pp. 2-9.
Czernielewski et al. Journal of European Academy of Dermatology and Venerology. Dec. 2001, vol. 15, Supplement 3, pp. 5-12.
Differin Gel Data Sheet, available as of Nov. 1998, pp. 1-5.
Allec et al., “Skin Distribution and Pharmaceutical Aspects of Adapalene Gel”, Journal of the American Academy of Dermatology, Inc., 1997, pp. S119-S125, vol. 36, No. 6, Part 2.
Shroot et al., “A new Concept of Drug Delivery for Acne,” Dermatology, 1998, pp. 165-170, vol. 196, No. 1, S. Karger AG Basel.
Rolland et al., “Site-Specific Drug Delivery to Pilosebaceous Structure Using Polymeric Microspheres,” Pharmaceutical Research, 1993, pp. 1738-1744, vol. 10, No. 12, Plenum Publishing Corp.
Jamoulle et al., “Follicular Penetration and Distribution of Topically Applied CD 271, a New Naphthoic Acid Derivative Intended for Topical Acne Treatment,” Journal of Investigation Dermatology, 1990, pp. 731-732, vol. 94, No. 5.
Alirezai et al., “Etude comparative de l'efficacite et de la tolerance de gels d'adapalene a 0, 1 et 0,03 p. 100 et d'un gel de tretinoine a 0,025 p. 100 dans le traitement de l'acne,” Ann. Dermatol. Venereol, 1996, pp. 165-170, vol. 123, No. 3, (Extensive Summary in English).
European Search Report for corresponding European Application EP 05 00 3144 (in English).
International Search Report for PCT/EP03/03246) (in English).
Czernielewski Janusz
Graeber Michael
Buchanan Ingersoll & Rooney P.C.
Galderma Research & Development
Jean-Louis Samira
Padmanabhan Sreeni
LandOfFree
Administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4054045